Evidence map›Paper›PMID 35202704›Full record

ArticleExperimental eye research2022

Minimal effect of conditional ferroportin KO in the neural retina implicates ferrous iron in retinal iron overload and degeneration.

Yingrui Liu, Bailey Baumann, Ying Song, Kevin Zhang, Jacob K Sterling, Samira Lakhal-Littleton, Zbynek Kozmik, Guanfang Su, Joshua L Dunaief

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Yingrui LiuDepartment of Ophthalmology, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun, Jilin, China; F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA.
Bailey BaumannF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA.
Ying SongF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA.
Kevin ZhangF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA.
Jacob K SterlingF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA.
Samira Lakhal-LittletonDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Zbynek KozmikInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic (ASCR), Prague, Czech Republic.
Guanfang SuDepartment of Ophthalmology, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun, Jilin, China. Electronic address: sugf2012@163.com.
Joshua L DunaiefF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, 422 Curie Blvd, Philadelphia, PA, USA. Electronic address: jdunaief@upenn.edu.
Penn Presbyterian Medical Center · USCzech Academy of Sciences, Institute of Molecular Genetics · CZSecond Affiliated Hospital of Jilin University · CNUniversity of Oxford · GB

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CLAIRE H MITCHELL · 1985 to 2026
$19.5M
Retinal Iron Transport in Health and DiseaseR01EY015240 · NEI · UNIVERSITY OF PENNSYLVANIA · PI JOSHUA L DUNAIEF · 2004 to 2026
$10.4M
IL-1Beta-Induced Retinal Iron Accumulation in Age-Related Macular DegenerationF30EY032339 · NEI · UNIVERSITY OF PENNSYLVANIA · PI STERLING, JACOB KHAN · 2021 to 2023
$121k
British Heart Foundation FS/12/63/29895Medical Research Council MR/V009567/1NEI NIH HHS F30 EY032339NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY015240
6 · The paper itself

Abstract

Iron-induced oxidative stress can cause or exacerbate retinal degenerative diseases. Retinal iron overload has been reported in several mouse disease models with systemic or neural retina-specific knockout (KO) of homologous ferroxidases ceruloplasmin (Cp) and hephaestin (Heph). Cp and Heph can potentiate ferroportin (Fpn) mediated cellular iron export. Here, we used retina-specific Fpn KO mice to test the hypothesis that retinal iron overload in Cp/Heph DKO mice is caused by impaired iron export from neurons and glia. Surprisingly, there was no indication of retinal iron overload in retina-specific Fpn KO mice: the mRNA levels of transferrin receptor in the retina were not altered at 7-10-months age. Consistent with this, levels and localization of ferritin light chain were unchanged. To "stress the system", we injected iron intraperitoneally into Fpn KO mice with or without Cp KO. Only mice with both retina-specific Fpn KO and Cp KO had modestly elevated retinal iron levels. These results suggest that impaired iron export through Fpn is not sufficient to explain the retinal iron overload in Cp/Heph DKO mice. An increase in the levels of retinal ferrous iron caused by the absence of these ferroxidases, followed by uptake into cells by ferrous iron importers, is most likely necessary.

Indexed as

Cation Transport ProteinsIron OverloadAnimalsCeruloplasminFerroportinIronMiceMice, KnockoutRetinaCation Transport ProteinsCeruloplasminFerroportinIronAge-related macular degenerationCeruloplasminFerroportinFerrousIronRetina

Identifiers

PMID35202704
PMCPMC9050912
OpenAlexW4213266453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.